Rimm DL - Search Results

1

PD-L1 Protein Expression on Both Tumor Cells and Macrophages are Associated with Response to Neoadjuvant Durvalumab with Chemotherapy in Triple-negative Breast Cancer.

Ahmed FS, Gaule P, McGuire J, Patel K, Blenman K, Pusztai L, Rimm DL. Ahmed FS, et al. Among authors: rimm dl. Clin Cancer Res. 2020 Oct 15;26(20):5456-5461. doi: 10.1158/1078-0432.CCR-20-1303. Epub 2020 Jul 24. Clin Cancer Res. 2020. PMID: 32709714 Free PMC article. Clinical Trial.

2

Expression of c-met is a strong independent prognostic factor in breast carcinoma.

Ghoussoub RA, Dillon DA, D'Aquila T, Rimm EB, Fearon ER, Rimm DL. Ghoussoub RA, et al. Among authors: rimm eb, rimm dl. Cancer. 1998 Apr 15;82(8):1513-20. doi: 10.1002/(sici)1097-0142(19980415)82:8<1513::aid-cncr13>3.0.co;2-7. Cancer. 1998. PMID: 9554529

3

Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma.

Camp RL, Rimm EB, Rimm DL. Camp RL, et al. Among authors: rimm eb, rimm dl. Cancer. 1999 Dec 1;86(11):2259-65. doi: 10.1002/(sici)1097-0142(19991201)86:11<2259::aid-cncr13>3.0.co;2-2. Cancer. 1999. PMID: 10590366

4

A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome.

Camp RL, Rimm EB, Rimm DL. Camp RL, et al. Among authors: rimm eb, rimm dl. Cancer. 2000 Jan 1;88(1):108-13. Cancer. 2000. PMID: 10618612

5

Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis.

Chung GG, Provost E, Kielhorn EP, Charette LA, Smith BL, Rimm DL. Chung GG, et al. Among authors: rimm dl. Clin Cancer Res. 2001 Dec;7(12):4013-20. Clin Cancer Res. 2001. PMID: 11751495

6

Immunocytochemical analysis of breast cells obtained by ductal lavage.

King BL, Crisi GM, Tsai SC, Haffty BG, Phillips RF, Rimm DL. King BL, et al. Among authors: rimm dl. Cancer. 2002 Aug 25;96(4):244-9. doi: 10.1002/cncr.10719. Cancer. 2002. PMID: 12209667 Free article.

7

Quantitative examination of mechanophysical tumor cell enrichment in fine-needle aspiration specimens.

Ernst LM, Rimm DL. Ernst LM, et al. Among authors: rimm dl. Cancer. 2002 Oct 25;96(5):275-9. doi: 10.1002/cncr.10746. Cancer. 2002. PMID: 12378594 Free article.

8

Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis.

Dolled-Filhart M, Camp RL, Kowalski DP, Smith BL, Rimm DL. Dolled-Filhart M, et al. Among authors: rimm dl. Clin Cancer Res. 2003 Feb;9(2):594-600. Clin Cancer Res. 2003. PMID: 12576423

9

Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome.

Camp RL, Dolled-Filhart M, King BL, Rimm DL. Camp RL, et al. Among authors: rimm dl. Cancer Res. 2003 Apr 1;63(7):1445-8. Cancer Res. 2003. PMID: 12670887

10

Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors.

Tolgay Ocal I, Dolled-Filhart M, D'Aquila TG, Camp RL, Rimm DL. Tolgay Ocal I, et al. Among authors: rimm dl. Cancer. 2003 Apr 15;97(8):1841-8. doi: 10.1002/cncr.11335. Cancer. 2003. PMID: 12673709 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

514 results

Search Page

Filters